{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:26:39Z","timestamp":1788863199176,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.athoracsur.2020.03.024","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T19:16:13Z","timestamp":1586632573000},"page":"398-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Preoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma"],"prefix":"10.1016","volume":"110","author":[{"given":"Syed Nabeel","family":"Zafar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffer A.","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannelyn S.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne L.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Badgwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4_suppl","key":"10.1016\/j.athoracsur.2020.03.024_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2019.37.4_suppl.40","article-title":"Incidence of gastroesophageal junction cancer continues to rise: analysis of Surveillance, Epidemiology, and End Results (SEER) database","volume":"37","author":"Bartel","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5230\/jgc.2019.19.e18","article-title":"History of esophagogastric junction cancer treatment and current surgical management in western countries","volume":"19","author":"Berlth","year":"2019","journal-title":"J\u00a0Gastric Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.soc.2016.10.009","article-title":"Controversies and consensus in preoperative therapy of esophageal and gastroesophageal junction cancers","volume":"26","author":"Ku","year":"2017","journal-title":"Surg Oncol Clin North Am"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib4","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib5","author":"Ajani"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib6","author":"Ajani"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib7","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.athoracsur.2008.01.097","article-title":"Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm","volume":"85","author":"Pennathur","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib8","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib10","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5230\/jgc.2019.19.e19","article-title":"Multimodal treatment strategies in esophagogastric junction cancer: a Western perspective","volume":"19","author":"Goetze","year":"2019","journal-title":"J\u00a0Gastric Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib12","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1245\/s10434-017-5827-1","article-title":"Preoperative chemoradiotherapy versus perioperative chemotherapy for patients with resectable esophageal or gastroesophageal junction adenocarcinoma","volume":"24","author":"Anderegg","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib13","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10120-018-0832-z","article-title":"Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: Analyses of the National Cancer Database 2006-2014 using propensity score matching","volume":"21","author":"Ikoma","year":"2018","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib14","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.athoracsur.2010.04.061","article-title":"Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer","volume":"90","author":"Swisher","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib15","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/jso.25089","article-title":"Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus","volume":"117","author":"Visser","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib16","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.athoracsur.2015.11.070","article-title":"Preoperative chemoradiation therapy versus chemotherapy in patients undergoing modified en bloc esophagectomy for locally advanced esophageal adenocarcinoma: is radiotherapy beneficial?","volume":"101","author":"Spicer","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy078","article-title":"Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: Long-term results of a randomized clinical trial","volume":"32","author":"von Dobeln","year":"2019","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib18","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejca.2010.09.009","article-title":"Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial","volume":"47","author":"Burmeister","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/annonc\/mdw010","article-title":"A\u00a0randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction","volume":"27","author":"Klevebro","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2017.04.027","article-title":"Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): long-term results of a controlled randomised trial","volume":"81","author":"Stahl","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12885-015-1529-x","article-title":"TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG\/TROG\/EORTC\/NCIC CTG)","volume":"15","author":"Leong","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib22","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1186\/s12885-018-4770-2","volume":"18","author":"Slagter","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-017-3386-2","article-title":"ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)","volume":"17","author":"Reynolds","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12885-016-2564-y","article-title":"Esopec: Prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)","volume":"16","author":"Hoeppner","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamasurg.2014.678","article-title":"The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery","volume":"150","author":"Morgan","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1245\/s10434-018-6396-7","article-title":"A\u00a0population-based study on lymph node retrieval in patients with esophageal cancer: results from the Dutch upper gastrointestinal cancer audit","volume":"25","author":"van der Werf","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib29","series-title":"Modeling Survival Data","author":"Therneau","year":"2000"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib30","article-title":"Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: a meta-analysis based on clinical trials","volume":"13","author":"Zhao","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/annonc\/mdw560","article-title":"Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study","volume":"28","author":"Markar","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib32","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1245\/s10434-019-07638-8","article-title":"Characteristics and survival of gastric cancer patients with pathologic complete response to preoperative therapy","volume":"26","author":"Stark","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.athoracsur.2020.03.024_bib33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1200\/JCO.2005.01.305","article-title":"Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome","volume":"23","author":"Ajani","year":"2005","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497520305324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497520305324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T04:03:23Z","timestamp":1757736203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497520305324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0003497520305324"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2020.03.024","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2020.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The Society of Thoracic Surgeons Published by Elsevier","name":"copyright","label":"Copyright"}]}}